Internal Medicine, Endocrinology, Diabetes, & Metabolism · Norfolk, VA
NPI
1447452776
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
850 Kempsville Rd 100e
Norfolk, VA, 23502
Phone (757) 261-5744
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
1,420 services
Medicare patients, 2024
347
Average age 73
Drug cost, 2024
$1.6M
3,772 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mandip Rawla was code 99214 (office e&m - established), 804 times for 293 patients. In total Mandip Rawla billed 1,420 services in 12 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 804 | 293 | $69.85 | $56K |
| 95251 Test - Miscellaneous | Facility | 406 | 135 | $26.04 | $11K |
| 36415 Venipuncture Blood Collection | Office | 45 | 21 | $8.65 | $389 |
| 99214 Office E&M - Established | Office | 39 | 17 | $35.34 | $1,378 |
| 99215 Office E&M - Established | Facility | 38 | 34 | $107.56 | $4,087 |
| 99213 Office E&M - Established | Facility | 26 | 24 | $42.34 | $1,101 |
| 99204 Office E&M - New | Facility | 22 | 22 | $88.45 | $1,946 |
By year: 2022 $67K for 1,127 services; 2023 $74K for 1,294 services; 2024 $77K for 1,420 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 45 | 21 | $8.65 | $389 |
Medicare prescription drug claims, 2024
In 2024, the drug Mandip Rawla prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 302 prescriptions and refills. In total Mandip Rawla wrote 3,772 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Er Metformin Hcl | 302 | 862 | 99 | $3,123 |
| Ozempic Semaglutide | 294 | 539 | 71 | $470K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 290 | 754 | 100 | $38K |
| Levothyroxine Sodium Generic | 279 | 763 | 84 | $3,554 |
| Glipizide Er Glipizide | 205 | 572 | 64 | $2,778 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 176 | 408 | 67 | $16K |
| Jardiance Empagliflozin | 167 | 395 | 46 | $220K |
| Synthroid Levothyroxine Sodium | 127 | 324 | 25 | $4,843 |
| Glimepiride Generic | 94 | 271 | 37 | $1,010 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 93 | 216 | 32 | $31K |
| Atorvastatin Calcium Generic | 89 | 236 | 27 | $894 |
| Humalog Kwikpen U-100 Insulin Lispro | 86 | 215 | 35 | $28K |
| Trulicity Dulaglutide | 82 | 135 | 19 | $125K |
| Humalog Insulin Lispro | 78 | 170 | 22 | $24K |
| Rosuvastatin Calcium Generic | 77 | 207 | 24 | $737 |
Brand drugs: 2,005 claims; generic drugs: 1,368 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mandip Rawla were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.